Diagnosis-to-treatment interval and control of locoregionally advanced head and neck cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 3, 2011, Pages 282-285

  Caudell, Jimmy J ^a,c   Locher, Julie L ^b   Bonner, James A ^c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOPSY; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CHILD; DIAGNOSIS TO TREATMENT INTERVAL; DISTANT METASTASIS; FEMALE; GROUPS BY AGE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; TIME; TREATMENT PLANNING; CARCINOMA, SQUAMOUS CELL; DELAYED DIAGNOSIS; DISEASE FREE SURVIVAL; INSURANCE; INTENSITY MODULATED RADIATION THERAPY; MORTALITY; OTORHINOLARYNGOLOGIC NEOPLASMS; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES;

ADULT; BIOPSY; CARCINOMA, SQUAMOUS CELL; DELAYED DIAGNOSIS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INSURANCE COVERAGE; MALE; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 79953044440     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.20     Document Type: Article

References (15)

1. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? a systematic review. J Clin Oncol. 2003;21(3):555-563. (Pubitemid 46606487)
2. Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5-10. (Pubitemid 47039177)
3. Bentzen SM, Thames HD. Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys. 1996; 36(1):247-251. (Pubitemid 26314173)
4. Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Mancuso AA. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2003;25(7):535-542. (Pubitemid 36736872)
5. Hoebers FJP, Pameijer FA, de Bois J, et al. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma. Head Neck. 2008;30(9):1216-1223.
6. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(4):929-936. (Pubitemid 34219010)
7. O'Sullivan B, Mackillop W, Grice B, et al. The influence of delay in the initiation of definitive radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys. 1998;42(1)(suppl 1):323.
8. Barton MB, Morgan G, Smee R, Tiver KW, Hamilton C, Gebski V. Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother Oncol. 1997;44(2):137-141.
9. Brouha XD, Op De Coul B, Terhaard CH, Hordijk GJ. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol Allied Sci. 2000;25(3):215-218.
10. Lee AW, Chan DK, Fowler JF, et al. T1 nasopharyngeal carcinoma: the effect of waiting time on tumor control. Int J Radiat Oncol Biol Phys. 1994;30(5):1111-1117. (Pubitemid 24362521)
11. Caudell JJ, Meredith RF, Spencer SA, Keene KS, Dobelbower MC, Bonner JA. Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;76(1):164-168.
12. Thind A, Hoq L, Diamant A, Maly RC. Satisfaction with care among low-income women with breast cancer. J Womens Health (Larchmt). 2010;19(1):77-86.
13. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612-619. (Pubitemid 351264356)
14. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
15. Hansen O, Larsen S, Bastholt L, Godballe C, Jørgensen KE. Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients. Int J Radiat Oncol Biol Phys. 2005;61(3):789-794. (Pubitemid 40247974)